Welcome to EverybodyWiki ! Nuvola apps kgpg.png Sign in or create an account to improve, watchlist or create an article like a company page or a bio (yours ?)...

GroupH

From EverybodyWiki Bios & Wiki
Jump to navigation Jump to search



groupH is an insights and advisory firm working across the pharmaceutical and biotech sectors.

groupHgroupH
Type
Private
IndustryPharmaceutical Consulting and Market Research
Founded 📆2005
Founder 👔
Headquarters 🏙️,
London
,
UK
Area served 🗺️
Worldwide
Key people
Erik Holzinger, Iain Clark, Morris Paterson, Nicolas Touchot, Sara Uttley
Members
Number of employees
Websitegrouph.com
address
telephone


History[edit]

groupH Ltd was set-up in April 2005, in London, by Erik Holzinger. In 2016, US operations were set up in San Francisco.

Industry Collaborations[edit]

groupH co-ordinates the EphMRA Online Forecasting Forum.  This is a forum for pharma companies and agencies to discuss topics of interest in areas of Forecasting and Data Analysis.

Publications[edit]

  • Approaches to manage 'affordability' of high budget impact medicines in key EU countries (2018)[1]
  • Early Insights from Commercialization of Gene Therapies in Europe (2017)[2]
  • Feasibility and attractiveness of indication value-based pricing in key EU countries (2016)[3]
  • The payers' perspective on gene therapies (2015)[4]
  • Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles (2013)[5]
  • Insomnia (2005) [6]

External Links[edit]

Official website https://grouph.com/

References[edit]

  1. Flume, Mathias; Bardou, Marc; Capri, Stefano; Sola-Morales, Oriol; Cunningham, David; Levin, Lars-Ake; Postma, Maarten J.; Touchot, Nicolas (2018-01-01). "Approaches to manage 'affordability' of high budget impact medicines in key EU countries". Journal of Market Access & Health Policy. 6 (1): 1478539. doi:10.1080/20016689.2018.1478539. PMC 5998770. PMID 29915664.
  2. Touchot, Nicolas; Flume, Mathias (February 2017). "Early Insights from Commercialization of Gene Therapies in Europe". Genes. 8 (2): 78. doi:10.3390/genes8020078. PMC 5333067. PMID 28218692.
  3. Flume, Mathias; Bardou, Marc; Capri, Stefano; Sola-Morales, Oriol; Cunningham, David; Levin, Lars-Ake; Touchot, Nicolas; Insight, On behalf of Payers’ (2016-01-01). "Feasibility and attractiveness of indication value-based pricing in key EU countries". Journal of Market Access & Health Policy. 4 (1): 30970. doi:10.3402/jmahp.v4.30970. PMC 4864834. PMID 27226845.
  4. Touchot, Nicolas; Flume, Mathias (2015-09-08). "The payers' perspective on gene therapies". Nature Biotechnology. 33 (9): 902–904. doi:10.1038/nbt.3332. ISSN 1546-1696. PMID 26348952.
  5. "Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles". In Vivo. 2013-02-19. Retrieved 2019-11-11.
  6. Holzinger, E. (May 2005). "Insomnia". IDrugs : The Investigational Drugs Journal. 8 (5): 410–415. ISSN 1369-7056. PMID 15883924.


This article "GroupH" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:GroupH. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.


Compte Twitter EverybodyWiki Follow us on https://twitter.com/EverybodyWiki !

Farm-Fresh comment add.png You have to Sign in or create an account to comment this article !